ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
16,954.40
-0.17%
다우존스 지수
37,903.29
0.23%
Bitcoin
57,461.79
-1.33%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. NRX Pharmaceuticals Inc (NRXP)

  7. NRX Pharmaceuticals Inc (NRXP) 뉴스

NRXP NRX Pharmaceuticals Inc

2.169
-0.411 (-15.93%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
NRX Pharmaceuticals Inc NRXP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.411 -15.93% 2.169 09:00:00
개장가 저가 고가 종가 전일 종가
2.06 2.02 2.30 2.18 2.58
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising..
18/04/202421:32PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from..
18/04/202421:30PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million..
18/04/202405:45PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
17/04/202421:30PRNUSNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data..
15/04/202421:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of..
08/04/202421:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of..
01/04/202421:28PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and..
28/03/202421:03PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth..
28/03/202421:00PRNUSNRx Pharmaceuticals Announces Reverse Stock Split to..
27/03/202405:03PRNUSUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth..
25/03/202421:30PRNUSNRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan..
22/03/202405:02PRNUSNRx Pharmaceuticals to Report Fourth Quarter and Full Year..
22/03/202402:57PRNUSNRx Pharmaceuticals Announces Results of the Vote Held..
12/03/202420:49PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to..
12/03/202406:16EDGAR2Form DEF 14A - Other definitive proxy statements
11/03/202421:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of..
07/03/202406:08EDGAR2Form 8-K - Current report
04/03/202422:30PRNUSNRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient,..
01/03/202422:30PRNUSNRx Pharmaceuticals Announces Definitive Purchase Agreement..
29/02/202407:09EDGAR2Form 8-K - Current report
29/02/202400:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/02/202400:49PRNUS/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./
27/02/202422:54PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million..
27/02/202407:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/02/202406:01PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
26/02/202422:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE..
20/02/202422:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE..
15/02/202406:30EDGAR2Form 8-K - Current report
14/02/202420:03EDGAR2Form 8-K - Current report
12/02/202422:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance..
09/02/202422:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by..
05/02/202420:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the..
03/02/202406:37EDGAR2Form 8-K - Current report
24/01/202406:16EDGAR2Form 8-K - Current report
22/01/202420:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces..
17/01/202420:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt..
17/01/202408:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/01/202421:25DJNNRx Pharmaceuticals Gets Fast-Track Designation for NRX-101..
16/01/202420:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA..
02/01/202422:45PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote..
02/01/202420:48PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance..
30/12/202306:30EDGAR2Form PRE 14A - Other preliminary proxy statements
30/12/202306:15EDGAR2Form 8-K - Current report
27/12/202320:48PRNUSNRx Pharmaceuticals Announces the Election of Janet..
22/12/202306:05EDGAR2Form 8-K - Current report
19/12/202322:15PRNUSNRx Pharmaceuticals Announces Signing of a Data and..
18/12/202320:48PRNUSNRx Pharmaceuticals Announces FDA Clearance of its..
14/12/202306:02PRNUSNRx Pharmaceuticals Provides Notice of Annual Meeting of..
11/12/202320:48PRNUSNRx Pharmaceuticals to Participate in LifeSci Corporate..

최근 히스토리

NASDAQ
NRXP
NRX Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유